Virologist treats breast cancer with oncolytic virotherapy, shrinking the tumor and boosting immune response. An ...

Virologist Beata Halassy, ​​facing a recurrent tumor, develops and tests on herself an innovative therapy: here is her story.

Imugene stocks well placed to grow with clinical progress on azer-cel CAR T-cell therapy and strong cash position, say analysts ...

Researchers have engineered an adenovirus to selectively target and kill aggressive brain cancer cells, which has shown ...

The Phase-1 OASIS (oncolytic assessment and safety in solid tumours ... and intravenous (IV) administrations of the therapy, ...

A scientist remarkably treated her own stage three cancer with viruses she was growing in the lab. Those who have been ...

Imugene expands CAR T-Cell and Oncolytic Virotherapy trials in Australia and the ... clinical trial of its azer-cel (azercabtagene zapreleucel) allogeneic CAR T-cell therapy.

A Croatian virologist, Beata Halassy, battling breast cancer recurrence, took a daring step by injecting herself with ...

TG4050: Promising Phase I data to be presented at SITC 2024 providing clinical proof of principle in adjuvant head and neck cancer setting Financial visibility confirmed into Q4 2025 Strasbourg, ...